NuCana plc (NCNA) Executive Compensation
NuCana plc (NCNA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NCNA
CIK: 1709626
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerKevin Weston
Audit LocationEdinburgh, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-30 | 2026-09-30 | 6-K | 0001193125-26-408365 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-06-30 | 6-K | 0001193125-26-349254 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-19 | 4 | 0001193125-26-280239 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | 4 | 0001193125-26-279925 | View SEC Doc Filr Page |
| 6-K | 2026-06-08 | 2026-06-08 | 6-K | 0001193125-26-260703 | View SEC Doc Filr Page |
| 6-K | 2026-06-01 | 2026-06-01 | 6-K | 0001193125-26-249817 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-05-14 | 6-K | 0001193125-26-224224 | View SEC Doc Filr Page |
| 6-K | 2026-05-06 | 2026-05-06 | 6-K | 0001193125-26-208951 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-15 | 4 | 0001193125-26-159162 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-03-18 | 3 | 0001193125-26-138044 | View SEC Doc Filr Page |
| 3 | 2026-03-24 | 2026-03-18 | 3 | 0001193125-26-121868 | View SEC Doc Filr Page |
| 3 | 2026-03-20 | 2026-03-18 | 3 | 0001193125-26-117653 | View SEC Doc Filr Page |
| 3 | 2026-03-19 | 2026-03-18 | 3 | 0001193125-26-116293 | View SEC Doc Filr Page |
| S-8 | 2026-03-19 | — | S-8 | 0001193125-26-116227 | View SEC Doc Filr Page |
| 20-F | 2026-03-19 | 2025-12-31 | 20-F | 0001193125-26-116030 | View SEC Doc Filr Page |
| 6-K | 2026-03-19 | 2026-03-19 | 6-K | 0001193125-26-115968 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-03-18 | — | SCHEDULE 13D Filing | 0001193125-26-114552 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 | 0001193125-26-114426 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 | 0001193125-26-114414 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 | 0001193125-26-114405 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 | 0001193125-26-114365 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 | 0001193125-26-114355 | View SEC Doc Filr Page |
| 6-K | 2026-01-06 | 2026-01-06 | 6-K | 0001193125-26-003489 | View SEC Doc Filr Page |
| 6-K | 2025-12-17 | 2025-12-17 | 6-K | 0001193125-25-321761 | View SEC Doc Filr Page |
| 6-K | 2025-12-10 | 2025-12-10 | 6-K | 0001193125-25-313499 | View SEC Doc Filr Page |